NCT01930461View on ClinicalTrials.gov

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
AsthmaHouse Dust Mite Allergy
Interventions
BIOLOGICAL

SLIT tablets of HDM allergen extracts, 3 different doses (A)

Two sublingual tablets daily for 13 months

BIOLOGICAL

SLIT tablets of HDM allergen extracts, 3 different doses (B)

Two sublingual tablets daily for 13 months

BIOLOGICAL

SLIT tablets of HDM allergen extracts, 3 different doses (C)

Two sublingual tablets daily for 13 months

BIOLOGICAL

Placebo matching the SLIT tablets of HDM allergen extracts

Two sublingual tablets daily for 13 months

Trial Locations (5)

10117

Universitätsmedizin Berlin - Allergie-Centrum-Charité, Berlin

34295

CHU Arnaud de Villeneuve, Montpellier

67091

NHC, Hôpitaux Universitaires de Strasbourg, Strasbourg

90-153

SPZOZ Uniwersytecki Szpital Kliniczny Nr 1im.N.Barlickiego w Uniwersystetu Medycznego w Łodzi, Lodz

33-100

Majorek-Olechowska Bernadetta, Tarnów

Sponsors

Lead Sponsor

Stallergenes Greer
All Listed Sponsors
lead

Stallergenes Greer

INDUSTRY

NCT01930461 - Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma | Biotech Hunter | Biotech Hunter